DC071
DrugMouthwash, twice daily
NCT Number: NCT02382809
The purpose of this study is to demonstrate the efficacy of 0.2 % digluconate chlorhexidine mouthwash in the prevention of alveolar osteitis following third molar extraction and to evaluate the safety and local tolerability.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Tallinn, Estonia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mouthwash, twice daily
Mouthwash, twice daily
Time frame: Within 7 days
The primary Outcome measure will be evaluated based on the absence/presence of an alveolar osteitis within 7 days after the extraction of the third molar.
Pierre Fabre Medicament
Industry
Efficacy of DC071 Mouthwash (0.2% Chlorhexidine Digluconate) in Peri-surgical Care for Preventing Alveolar Osteitis After Third Molar Extraction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07139340
Alveolar Osteitis, Dry Socket
Gamasa, Dakahlia Governorate, Egypt
View Trial DetailsNCT06481293
Alveolar Osteitis, Dry Socket
Cairo, Egypt
View Trial DetailsNCT06865508
Alveolar Osteitis, Dry Socket
Cairo, Egypt
View Trial DetailsNCT06761001
Alveolar Osteitis, Dry Socket
Eskişehir, Turkey (Türkiye)
View Trial Details